FDA May Be Considering Ending In-Person Meetings With Sponsors

FDA is considering continuing virtual meetings with the sponsor even after the pandemic, announced CDER’s Director, Dr. Patrizia Cavazzoni, at a public meeting last week. Its reasoning that sponsors would find virtual meetings convenient over the hassle of traveling to FDA’s offices, seems to be based on anecdotes rather than formal surveys or any studies. … Read more